Methotrexate companies

  • Report ID: 6872
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

Methotrexate Market Players:

    Key players in the methotrexate market are employing several organic and inorganic tactics such as new product launches, technological innovations, investments in R&D, strategic collaborations & partnerships, mergers & acquisitions, and global expansions to earn high profits and maximize their presence. Industry giants are collaborating with research organizations and partnering with other players to develop innovative methotrexate drug formulations. They are also acquiring smaller pharma companies or start-ups with advanced methotrexate formulations to expand their product offering at minimum CAPEX. Furthermore, the regional expansion tactics are aiding them to grab untapped opportunities.

    Some of the key players include in methotrexate market:

    • Pharmascience, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Eversana Life Science Services, LLC
    • Elite Pharmaceuticals, Inc.
    • STAQ Pharma
    • PrecisePK
    • Novartis AG
    • Pfenex, Inc.
    • Zydus Lifesciences
    • Alvogen
    • Teva Pharmaceutical Industries
    • Bristol-Myers Squibb
    • Mylan N.V.
    • Hikma Pharmaceuticals Plc
    • Fresenius Kabi
    • Reddy's Laboratories
    • Aurobindo Pharma Ltd
    • Accord Healthcare Limited
    • Amgen, Inc.
    • Sun Pharmaceutical Industries
    • Sandoz Group AG

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of methotrexate is assessed at USD 1.24 billion.

The global methotrexate market size was valued at over USD 1.19 billion in 2025 and is expected to expand at a CAGR of over 4.7%, surpassing USD 1.88 billion revenue by 2035.

North America methotrexate market will account for 33.70% share by 2035, driven by presence of advanced healthcare facilities and rising prevalence of autoimmune diseases.

Key players in the market include Pfenex, Inc., Zydus Lifesciences, Alvogen, Teva Pharmaceutical Industries, Bristol-Myers Squibb, and Mylan N.V.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos